We are live on
!
Find out more
NHAS
Novo Holdings A/S Portfolio holdings
AUM
$1.23B
1-Year Est. Return
81.32%
This Fund
S&P 500
This Quarter
Est. Return
-10.8%
1 Year Est. Return
+81.32%
3 Year Est. Return
+192.63%
5 Year Est. Return
+125.03%
10 Year Est. Return
+943.65%
AUM
$1.9B
AUM Growth
-$216M
(-10%)
Cap. Flow
+$51.8M
Cap. Flow
% of AUM
2.73%
Top 10 Holdings %
Top 10 Hldgs %
68.43%
Holding
55
New
7
Increased
8
Reduced
10
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASML
ASML
|
+$144M |
| 2 |
CTLT
CATALENT, INC.
CTLT
|
+$133M |
| 3 |
ACLX
Arcellx
ACLX
|
+$67.2M |
| 4 |
Salesforce
CRM
|
+$64.3M |
| 5 |
TSMC
TSM
|
+$53.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXAI
Exscientia Plc American Depositary Shares
EXAI
|
+$259M |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$91.8M |
| 3 |
Apple
AAPL
|
+$51.8M |
| 4 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
+$17.4M |
| 5 |
ZGNX
Zogenix, Inc.
ZGNX
|
+$7.19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 48.98% |
| 2 | Technology | 19.33% |
| 3 | Financials | 8.72% |
| 4 | Consumer Discretionary | 2.87% |
| 5 | Communication Services | 1.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vanguard Morningstar Total Stock Market ETF
VTI
$646B
| $347M | 18.32% |
1,525,550
-408,350
| -21% | -$91.8M |
|
2
Brookfield
BN
$102B
| $165M | 8.72% |
5,420,233
| – | – |
|
3
Boston Scientific
BSX
$68.4B
| $153M | 8.09% |
3,463,577
| – | – |
|
|
4
ASML
ASML
$596B
| $144M | 7.58% |
+215,099
| New | +$144M |
|
|
CTLT
5
DELISTED
CATALENT, INC.
CTLT
| $141M | 7.44% |
+1,271,707
| New | +$133M |
|
|
6
Apple
AAPL
$4.97T
| $107M | 5.63% |
610,879
-308,000
| -34% | -$51.8M |
|
|
MORF
7
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $65.6M | 3.46% |
1,634,811
-415,635
| -20% | -$17.4M |
|
|
8
Salesforce
CRM
$154B
| $63.5M | 3.35% |
+299,000
| New | +$64.3M |
|
|
ACLX
9
DELISTED
Arcellx
ACLX
| $56.3M | 2.97% |
+4,016,878
| New | +$67.2M |
|
10
Alibaba
BABA
$276B
| $54.5M | 2.87% |
500,827
| – | – |
|
11
Edgewise Therapeutics
EWTX
$4.28B
| $54.2M | 2.86% |
5,587,207
| – | – |
|
12
Mirum Pharmaceuticals
MIRM
$6.56B
| $48.4M | 2.56% |
2,200,000
-245,147
| -10% | -$5M |
|
|
13
TSMC
TSM
$1.94T
| $47.8M | 2.52% |
+458,780
| New | +$53.7M |
|
14
Inogen
INGN
$174M
| $34.8M | 1.83% |
1,072,735
| – | – |
|
15
Nkarta
NKTX
$152M
| $31.8M | 1.68% |
2,793,863
-1
| -0% | -$11 |
|
|
FOLD
16
DELISTED
Amicus Therapeutics
FOLD
| $24.2M | 1.28% |
2,560,211
| – | – |
|
17
Cable One
CABO
$237M
| $23.2M | 1.23% |
15,873
| – | – |
|
|
CYT
18
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $18.2M | 0.96% |
4,840,413
| – | – |
|
|
IOBT
19
DELISTED
IO Biotech
IOBT
| $17.4M | 0.92% |
3,277,932
| – | – |
|
|
VERV
20
DELISTED
Verve Therapeutics
VERV
| $17.1M | 0.9% |
750,000
+50,000
| +7% | +$1.43M |
|
21
Insmed
INSM
$22.4B
| $16.6M | 0.88% |
705,838
+9,998
| +1% | +$232K |
|
22
Milestone Pharmaceuticals
MIST
$129M
| $16.2M | 0.86% |
2,530,003
-582
| -0% | -$3.64K |
|
|
VECT
23
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| $15.9M | 0.84% |
3,380,402
-141,617
| -4% | -$740K |
|
|
LVTX
24
DELISTED
LAVA Therapeutics
LVTX
| $14.6M | 0.77% |
3,327,312
| – | – |
|
|
BPMC
25
DELISTED
Blueprint Medicines
BPMC
| $14.5M | 0.77% |
227,526
+30,526
| +15% | +$2.19M |
|
Similar funds
HCA
GX
MP
FLII
IC
CCA
WCM
IA
Novo Holdings A/S's Q1 2022 Portfolio in Review
As of Q1 2022, Novo Holdings A/S held 55 positions worth $1.9B, down 10% from $2.11B the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Novo Holdings A/S's Q1 2022 filing shows 7 new, 8 increased, 10 reduced and 4 closed positions. Its largest new stake was ASML: 215,099 shares worth $144M. The largest sale was Exscientia Plc American Depositary Shares, an estimated $259M.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 57% a quarter earlier, followed by Technology and Financials.
- Novo Holdings A/S's largest Q1 2022 buy was ASML: 215,099 shares worth $144M.
- Novo Holdings A/S added most to Silk Road Medical, Inc. Common Stock in Q1 2022, an estimated $4.52M increase.
- Novo Holdings A/S's biggest Q1 2022 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $91.8M.
- Novo Holdings A/S fully exited Exscientia Plc American Depositary Shares in Q1 2022, selling an estimated $259M.
- Novo Holdings A/S's ten largest holdings make up 68% of its $1.9B portfolio in Q1 2022.
- Novo Holdings A/S opened 7 new positions and closed 4 in Q1 2022.
- Novo Holdings A/S's portfolio value fell 10% quarter-over-quarter to $1.9B.
Based on Novo Holdings A/S's 13F filing for Q1 2022, filed 16 May 2022.